| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.35▲ | 1.35▲ | 1.35▲ | 1.55▼ | 1.58▼ |
| MA10 | 1.35▲ | 1.36▲ | 1.38▼ | 1.60▼ | 2.16▼ |
| MA20 | 1.37▲ | 1.39▼ | 1.43▼ | 1.61▼ | 2.68▼ |
| MA50 | 1.42▼ | 1.53▼ | 1.59▼ | 2.30▼ | 1.24▲ |
| MA100 | 1.53▼ | 1.60▼ | 1.91▼ | 2.71▼ | N/A |
| MA200 | 1.65▼ | 2.17▼ | 2.68▼ | 1.49▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.006▲ | 0.000▲ | 0.020▲ | -0.261▼ |
| RSI | 46.638▼ | 39.997▼ | 37.332▼ | 32.600▼ | 42.070▼ |
| STOCH | 36.429 | 21.875 | 22.937 | 32.198 | 8.939▼ |
| WILL %R | -45.000 | -50.000 | -65.625 | -92.254▼ | -97.817▼ |
| CCI | 36.086 | 13.939 | -44.520 | -193.365▼ | -113.375▼ |
|
Thursday, January 22, 2026 06:44 AM
The drug discovery company, which also invests in solar energy assets, revealed that its wholly-owned subsidiary MitoCareX Bio has demonstrated in vitro inhibition of pro-inflammatory responses in ...
|
|
Thursday, January 22, 2026 04:52 AM
MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases – ...
|
|
Thursday, January 15, 2026 05:50 AM
Prof. Ciro Leonardo Pierri's expertise in structural biology, mitochondrial carrier modeling, and drug targeting—demonstrated through his contributions to this and other related publications—underpins ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/01/26 | 1.37 | 1.39 | 1.32 | 1.375 | 94,704 |
| 27/01/26 | 1.37 | 1.468 | 1.35 | 1.45 | 139,792 |
| 26/01/26 | 1.56 | 1.56 | 1.43 | 1.46 | 260,640 |
| 23/01/26 | 1.68 | 1.75 | 1.61 | 1.63 | 554,135 |
| 22/01/26 | 1.92 | 2.03 | 1.51 | 1.81 | 45,740,684 |
| 21/01/26 | 1.53 | 1.70 | 1.51 | 1.65 | 47,849 |
| 20/01/26 | 1.57 | 1.63 | 1.539 | 1.57 | 18,981 |
| 16/01/26 | 1.67 | 1.78 | 1.61 | 1.62 | 89,288 |
| 15/01/26 | 1.46 | 1.80 | 1.40 | 1.75 | 1,934,365 |
| 14/01/26 | 1.58 | 1.68 | 1.57 | 1.66 | 24,923 |
|
|
||||
|
|
||||
|
|